-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DhmXdmBz2wQeh7r0U5aDt+/nS7wWR5Sl4r8s/AEpgW6ZoECckz25VFGVg33fLjYE ZvebLl5J+nSjdrAqDYeyWw== 0001181431-09-055236.txt : 20091204 0001181431-09-055236.hdr.sgml : 20091204 20091204194840 ACCESSION NUMBER: 0001181431-09-055236 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091130 FILED AS OF DATE: 20091204 DATE AS OF CHANGE: 20091204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lorianne Masuoka K. CENTRAL INDEX KEY: 0001466086 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 091224717 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 201 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6506313100 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 3 1 rrd259045.xml X0203 3 2009-11-30 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001466086 Lorianne Masuoka K. C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070 0 1 0 0 SVP & Chief Medical Officer Stock Option 3.97 2016-08-28 Common Stock 180000 D Stock Option 4.65 2017-02-23 Common Stock 40000 D Stock Option 4.65 2017-02-23 Common Stock 60000 D Stock Option 5.91 2017-06-16 Common Stock 100000 D Stock Option 8.76 2017-11-23 Common stock 160000 D 25% of the shares subject to the stock option vest on the one year anniversary of the grant date and the remainder of the shares vest pro-rata on a monthly basis over the following three years. The shares subject to the stock option vest pro-rata on a monthly basis over four years from the date of grant. Gil M. Labrucherie - Attorney-in-Fact 2009-12-04 -----END PRIVACY-ENHANCED MESSAGE-----